SiteOne Therapeutics Garners $1,500,000 New Funding

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=66661bbc-d22d-4fe6-aac5-e8bf07fafdf2
Date
9/25/2014
Company Name
SiteOne Therapeutics
Mailing Address
953 Indiana Street San Francisco, CA 94107 USA
Company Description
SiteOne Therapeutics, located in San Francisco, is developing novel therapeutics and diagnostics to safely, effectively and efficiently treat acute and chronic pain without the limitations of existing therapies, such as NSAIDs and opioids.
Website
http://www.site1therapeutics.com
Transaction Type
Venture Equity
Transaction Amount
$1,500,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes will be used to advance its oral Na?1.7 inhibitor program for pain and to further develop its technology platform for long-acting local analgesics, pain diagnostics and other pain indications.
M&A Terms
Venture Investor
Venture Investor
Venture Investor